April 22, 2024

Geschäftsanbahnungsreise Biotech – Vereinigtes Königreich (London & Cambridge)

Geschäftsanbahnungsreise Biotech – Vereinigtes Königreich (London & Cambridge)
Go back

Geschäftsanbahnungsreise Biotech – Vereinigtes Königreich (London & Cambridge)  

Target group:  German companies from the Biotech sector

Dates:  11–14 May 2026

Target region:  United Kingdom, London, Cambridge and Stevenage

Local partner onsite:  Life Science Integrates (LSI)

Organizer:  Market Entry Program of the Federal Ministry for Economic Affairs and Energy
(BMWE)

Registration deadline:  31 January 2026 (or until all spots are filled)

Vom 11.05. bis zum 14.05.2026 führt in2newmarkets, im Auftrag des Bundesministeriums für Wirtschaft und
Energie (BMWE), eine Geschäftsanbahnungsreise ins Vereinigte Königreich durch. Es handelt sich dabei um eine
projektbezogene Fördermaßnahme. Sie ist Bestandteil der Exportinitiative Gesundheitswirtschaft und wird im
Rahmen des Markterschließungsprogramms für KMU durchgeführt. Zielgruppe sind vorwiegend kleine und mittlere deutsche Unternehmen (KMU).

Anmeldeunterlagen GAB UK Biotech

Infoletter GAB Biotech UK 2026

register now

Our latest News

discover more
Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

Basel, Switzerland, 8 May 2026 – Today, Lonza Group Ltd held its Annual General Meeting (AGM), led by the Chair of the Board of Directors, Jean-Marc Huët. 62.58% of the share capital was represented at the AGM, with attending and represented shareholders collectively holding a total of 43,948,027 shares.  All Board members standing for re-election were re-elected, each for a further term in office until the completion of the AGM 2027. The following Board members stood for re-election: Jean-Marc Huët, Juan […]

read more
A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis

A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis

Led by researchers from Heidelberg Faculty of Medicine at Heidelberg University and the University of California, San Francisco (USA), an international research team has evaluated a novel approach for the diagnosis of pulmonary tuberculosis. The method enables detection of Mycobacterium tuberculosis without laboratory infrastructure, within a markedly shorter time frame than conventional diagnostics, and using […]

read more
Hella Bühler Prize Awarded to DKFZ Researcher Angelika Feldmann

Hella Bühler Prize Awarded to DKFZ Researcher Angelika Feldmann

For her groundbreaking research on the regulation of gene activity, Angelika Feldmann has been awarded the 2026 Hella Bühler Prize, which comes with a grant of €100,000. Presented by Heidelberg University, the award is intended for young researchers in the Heidelberg research community who have already distinguished themselves through outstanding scientific achievements in cancer research. […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp